Designing Health, Inc. v. Erasmus

226 F. App'x 976
CourtCourt of Appeals for the Federal Circuit
DecidedFebruary 26, 2007
Docket2006-1244
StatusUnpublished

This text of 226 F. App'x 976 (Designing Health, Inc. v. Erasmus) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Designing Health, Inc. v. Erasmus, 226 F. App'x 976 (Fed. Cir. 2007).

Opinion

DECISION

SCHALL, Circuit Judge.

Designing Health, Inc.; Robert M. Collett; and Bernard Collett, (collectively “DH”) appeal from the final judgment of the United States District Court for the Central District of California granting judgment pursuant to the Federal Circuit’s mandate of August 10, 2005. Designing Health, Inc. v. Erasmus, No. CV 98-4755 (C.D. Cal Jan. 23, 2006) (“Final Judgment”). DH argues on appeal that the district court erred in finding that the Federal Circuit’s decision 1) mandated entry of judgment as a matter of law (“JMOL”) in favor of both Flora Inc., Flora Manufacturing and Distributing, Ltd. (collectively “Flora”) and Udo Erasmus (“Erasmus”), and 2) precluded a new trial. Additionally, DH argues that the district court erred in declining to exercise its discretion to grant a new trial in the event the Federal Circuit’s decision did not mandate entry of JMOL in favor of Flora and Erasmus and did not preclude a new trial. Flora and Erasmus counter that the district court properly concluded that the Federal Circuit mandate of August 10, 2005, compelled entry of JMOL in favor of Flora and Erasmus and that it had no discretion to grant a new trial. Because the district court properly executed our mandate of August 10, 2005, we affirm.

DISCUSSION

I.

DH, a manufacturer of health food supplements, previously brought suit against Flora and Erasmus in the Central District of California alleging conspiracy to commit fraud, breach of fiduciary duty, and patent infringement. The district court dismissed the patent .infringement claims, denied Flora’s and Erasmus’ motions for judgment as a matter of law, and entered judgment, upon a jury verdict, in favor of DH on the fraud and breach of fiduciary duty claims. Erasmus and Flora appealed the decision of the district court denying their motion for JMOL regarding (1) the jury verdict that they were liable for fraud; (2) the jury’s award of damages resulting from that fraud; and (3) the jury’s verdict that they were liable for conspiracy to commit fraud. Erasmus appealed the decision of the district court denying his motion for JMOL regarding (1) the jury’s verdict that he was hable for breach of fiduciary duty; and (2) the jury’s award of damages for that breach.

On June 1, 2005, this court issued a decision on the prior appeal. Designing Health, Inc. v. Erasmus, 132 Fed.Appx. 826 (Fed.Cir.2005) (unpublished decision) (“DH I”). This court affirmed the district court’s denial of JMOL with respect to the jury’s liability verdicts against Flora and Erasmus but reversed the district court’s denial of JMOL as to damages against both Flora and Erasmus, holding that the record evidence was insufficient as a matter of law to support the jury’s fraud and breach of fiduciary duty damages awards. Id. at 833-34.

On June 27, 2005, DH filed a petition for rehearing requesting “clarification by the Court to provide limited direction to the district court, that the case is remanded for a new trial on damages and punitive damages at the district court’s discretion in accordance with Federal Rule of Civil Procedure Rule 50(d).” The petition for rehearing was denied without comment on August 3, 2005.

*978 II.

After this court’s mandate in DH I issued on August 10, 2005, the district court granted Flora and Erasmus’ renewed motions for JMOL, stating:

Pursuant to the Federal Circuit’s June 1, 2005 opinion and August 10, 2005 mandate ordering reversal of this court’s order denying Defendants’ motions for judgment as a matter of law (“JMOL”), the Court hereby VACATES the prior order of this court denying said motions, and enters a new order GRANTING said motions. Plaintiffs’ motion for a new trial is DENIED.

Designing Health, Inc. v. Flora, Inc., No. CV-98-4758, at 1 (C.D. Cal Nov. 17, 2006). The court also denied DH’s request for a new trial, stating:

The order of the Circuit Court is clear on its face in compelling reversal of the denial of the JMOLs. However, Plaintiffs have argued they are entitled to a new trial because evidence that might have supported the damages awards was allegedly improperly excluded at trial. This is an issue that should have been raised on appeal, either in the briefing or in the Petition for Rehearing. It is not for this court to now, for the first time, consider what is, in essence, an appeal from the orders of the prior Judge in this case____However, as the issues were not raised on appeal, the appellate court did not consider a new trial or order this court to do so. Accordingly, this court has no discretion in the matter.

Id. The court also noted that even if it had discretion to grant a new trial it would not have exercised its discretion to grant a new trial in this case. Id. The court entered judgment on January 23, 2006, stating: “(1) Plaintiffs . [DH] shall take nothing from Defendants Flora Inc., Flora Manufacturing and Distributing, Ltd., and Udo Erasmus on their claim for fraud; (2) Plaintiffs [DH] shall take nothing from Udo Erasmus on their claim for breach of fiduciary duty; and (3) costs be awarded to said Defendants under Federal Rule of Civil Procedure 54(d).” Final Judgment, at 1.

III.

This court reviews the interpretation of its own mandate de novo. Engel Indus., Inc. v. Lockformer Co., 166 F.3d 1379,1382 (Fed.Cir.1999); see also Tronzo v. Biomet, Inc., 236 F.3d 1342 (Fed.Cir.2001).

DH argues on appeal that the district court erred in finding that the Federal Circuit’s decision mandated entry of JMOL in favor of both Flora and Erasmus on damages, and thus precluded a new trial on damages. DH urges that Weisgram v. Marley Co., 528 U.S. 440, 120 S.Ct. 1011, 145 L.Ed.2d 958 (2000), implies a notice requirement whereby a court of appeals must be explicit when it directs a district court to enter judgment for the jury verdict loser in order to put the jury verdict winner on notice that it must seek a new trial before the court of appeals. According to DH, absent this explicit notice, a court of appeals’ silence in the mandate should not be construed by the district court as requiring entry of judgment for the jury verdict loser. Rather, the jury verdict winner should be free to seek, and the district court should have the discretion to grant, a new trial on remand. DH further argues that the district court’s denial of a new trial on damages was inconsistent with DH’s Seventh Amendment right to a jury trial. DH further outlines several alleged evidentiary failings by the district court which DH asserts support allowing a new trial on damages.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
226 F. App'x 976, Counsel Stack Legal Research, https://law.counselstack.com/opinion/designing-health-inc-v-erasmus-cafc-2007.